Papa Murphy's Holdings (FRSH) PT Lowered to $5 at Jefferies; Remains Sidelined
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
After-Hours Stock Movers 05/10: (SGMO) (RELY) (PEGA) Higher; (NH) (SNAP) (MNKD) Lower (more...)
May 10, 2017 6:25 PM EDTToday's After-Hours Movers
Sangamo Therapeutics, Inc. (Nasdaq: SGMO) 39% HIGHER; Sangamo and Pfizer Inc. (NYSE: PFE) today announced an exclusive, global collaboration and license agreement for the development and commercialization of gene therapy programs for Hemophilia A, including SB-525, one of Sangamo's four lead product candidates, which Sangamo expects will enter the clinic this quarter.
NantHealth (NASDAQ: NH) 24% LOWER; reported Q1 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20). Revenue for the quarter... More
Papa Murphy's (FRSH) Misses Q1 EPS by 25c, Miss on Revenues; Increases FY17 Cash FLlow Outlook
May 10, 2017 4:12 PM EDTPapa Murphy's (NASDAQ: FRSH) reported Q1 EPS of ($0.32), $0.25 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $32 million versus the consensus estimate of $35.21 million.
... More
